Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Expert Review of Cardiovascular Therapy
|
November 8, 2016
Ectopic fat: a target for cardiometabolic risk management
Amalia Gastaldelli, Melania Gaggini
Antioxidants (Basel, Switzerland)
|
May 28, 2022
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
Cristina Vassalle, Melania Gaggini
Expert Review of Cardiovascular Therapy
|
December 23, 2016
Response to: Drug therapy for ectopic fat: myth or reality?
Amalia Gastaldelli, Melania Gaggini
International Journal of Molecular Sciences
|
December 23, 2023
Lipids Metabolism and Cardiometabolic Diseases
Melania Gaggini, Cristina Vassalle
Biomolecules
|
May 4, 2026
Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology
Melania Gaggini, Cristina Vassalle
Hormone Molecular Biology and Clinical Investigation
|
September 25, 2017
The color of fat and its central role in the development and progression of metabolic diseases
Melania Gaggini, Fabrizia Carli, Amalia Gastaldelli
Hepatology (Baltimore, Md.)
|
December 2, 2017
Reply
Melania Gaggini, Elisabetta Bugianesi, Amalia Gastaldelli
Hormone Molecular Biology and Clinical Investigation
|
March 28, 2015
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases
Melania Gaggini, Chiara Saponaro, Amalia Gastaldelli
International Journal of Molecular Sciences
|
December 9, 2023
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Antioxidants (Basel, Switzerland)
|
May 27, 2023
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
Melania Gaggini, Simona Fenizia, Cristina Vassalle
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Expert Review of Cardiovascular Therapy
|
November 8, 2016
Ectopic fat: a target for cardiometabolic risk management
Amalia Gastaldelli, Melania Gaggini
Antioxidants (Basel, Switzerland)
|
May 28, 2022
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
Cristina Vassalle, Melania Gaggini
Expert Review of Cardiovascular Therapy
|
December 23, 2016
Response to: Drug therapy for ectopic fat: myth or reality?
Amalia Gastaldelli, Melania Gaggini
International Journal of Molecular Sciences
|
December 23, 2023
Lipids Metabolism and Cardiometabolic Diseases
Melania Gaggini, Cristina Vassalle
Biomolecules
|
May 4, 2026
Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology
Melania Gaggini, Cristina Vassalle
Hormone Molecular Biology and Clinical Investigation
|
September 25, 2017
The color of fat and its central role in the development and progression of metabolic diseases
Melania Gaggini, Fabrizia Carli, Amalia Gastaldelli
Hepatology (Baltimore, Md.)
|
December 2, 2017
Reply
Melania Gaggini, Elisabetta Bugianesi, Amalia Gastaldelli
Hormone Molecular Biology and Clinical Investigation
|
March 28, 2015
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases
Melania Gaggini, Chiara Saponaro, Amalia Gastaldelli
International Journal of Molecular Sciences
|
December 9, 2023
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Antioxidants (Basel, Switzerland)
|
May 27, 2023
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
Melania Gaggini, Simona Fenizia, Cristina Vassalle
Page
of 9